• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services

by March 25, 2025
written by March 25, 2025

The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote. 

The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.   

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate. 

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. 

On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump not planning to fire Waltz after national security text chain leak
next post
Dem senator calls for Waltz, Hegseth to resign as Gabbard says no classified material shared in Signal

related articles

Trump eyes next attorney general as key GOP...

April 3, 2026

US pilot rescued from downed F-15E fighter jet...

April 3, 2026

State top cop moves to crush alleged DHS...

April 3, 2026

Karoline Leavitt says Jean-Pierre had ‘hard time’ as...

April 3, 2026

Celebrity chef lashes out at Trump for changing...

April 3, 2026

What B-52 bombers bring to Iran fight —...

April 3, 2026

GOP targets transgender animal testing in defund demand...

April 3, 2026

VP Vance to meet with Viktor Orbán in...

April 3, 2026

WATCH: President Trump reveals families of slain US...

April 3, 2026

Justice Jackson sparks online uproar after linking birthright...

April 2, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Former NY congressman lays out Dems’ years-long escalating rhetoric ahead of Trump assassination attempt

    July 17, 2024
  • ApeCoin and Akita Inu: ApeCoin rises to a three-week high

    August 22, 2024
  • SCOTUS to hear straight woman’s discrimination case that could reshape employment law

    February 26, 2025
  • Nvidia stock soars on Wednesday: here’s what is pushing NVDA’s latest rally

    January 1, 2026
  • S&P 500 climbed 0.3%, and Nasdaq-100 futures jumped 0.7%

    December 4, 2024

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025
  • 5

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,470)
  • Investing (1,569)
  • Stock (1,012)

Latest Posts

  • Will Vance remark about US bailing on Ukraine encourage Putin to sink nascent peace talks?

    May 21, 2025
  • Trump’s House GOP allies demand swift confirmation of Cabinet picks amid delays

    January 16, 2025
  • The great airlift: how Apple ferried 1.5M iPhones from India to the US to beat Trump tariffs

    April 10, 2025

Recent Posts

  • Target rolls back DEI initiatives, the latest big company to retreat

    January 25, 2025
  • Which social media platforms have banned Trump and why? An overview

    August 5, 2024
  • Lithuanian defense minister: Only way to negotiate with Russia is with a ‘gun on the table’

    March 10, 2025

Editor’s Pick

  • Hispanics helped Trump win. Here’s how Republicans build on those gains

    November 8, 2024
  • King Charles sends personal message of congratulations to Trump on swearing-in

    January 21, 2025
  • Hunter Biden accused of ghosting daughter with Lunden Roberts and violating child support agreement

    January 16, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock